Matrix Lab receives WHO approval for Lopinavir and Ritonavir Tablets

Matrix Laboratories announced that it has received the first and only World Health Organization (WHO) approval for Lopinavir and Ritonavir Tabletsin strenghts of 200 mg and 50 mg respectively. Matrix`s version of this product is heat-stable and affordable, making it practical for distribution and use in warm climates